Timothy M Markman1, David Bluemke2, Elsayed Z Soliman3, Colin Wu4, Nadine Kawel-Boehm5, Joao A C Lima6, Saman Nazarian7. 1. Department of Medicine, The Johns Hopkins University, Baltimore, MD, United States of America; Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA, United States of America. Electronic address: timothy.markman@uphs.upenn.edu. 2. Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States of America. 3. Department of Internal Medicine, Section on Cardiology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America. 4. National Heart, Lung, and Blood Institute, Bethesda, MD, United States of America. 5. Department of Radiology, Kantonsspital Graubuenden, Chur, Switzerland. 6. Department of Medicine, The Johns Hopkins University, Baltimore, MD, United States of America; Division Cardiology, The Johns Hopkins University, Baltimore, MD, United States of America. 7. Department of Medicine, The Johns Hopkins University, Baltimore, MD, United States of America; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America; Division of Cardiology, Section for Cardiac Electrophysiology, The Johns Hopkins University, Baltimore, MD, United States of America; Division of Cardiology, Section for Cardiac Electrophysiology, Hospital of the University of Pennsylvania, Philadelphia, PA, United States of America.
Abstract
BACKGROUND: The mechanism of ST elevation on baseline electrocardiograms (ECG) unknown but it may be associated with abnormal myocardial substrate. This paper evaluates whether clinically unrecognized myocardial scar on cardiac magnetic resonance imaging (CMR) is associated with ST elevation at baseline. METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) study is a population-based cohort in the United States. Participants were aged 45 through 84 years and free of clinical cardiovascular disease at enrollment in 2000-2002. Our cohort included 1365 participants who underwent both ECG and contrast enhanced CMR in the 5th examination (2010-2012). Multivariable logistic regression examined the association of ST elevation and CMR defined regional myocardial scar after adjusting for cardiovascular risk factors. RESULTS: Of 1365 participants (58 ±9 years, 52% men), 105 (8%) had scar on CMR. Of these, the scar in 40 participants followed an ischemic pattern and in the other 65 participants followed a non-ischemic pattern. ST elevation at the 5th examination was present in 435 participants: 40 (0.9%) had ST elevations in inferior and 427 (98%) in lateral leads. 2/40 (5%) and 22/427 (5%) participants with inferior and lateral ST elevations, respectively, had evidence of scar. 15 (1.0%) had myocardial scar noted in the basal anterior region. In the fully adjusted models, ST elevation was associated with scar in basal anterior region (OR 18.2, p = 0.031). CONCLUSIONS: In a community population, ST elevation at baseline in the inferior or lateral leads was associated with myocardial scar in the basal inferior and anterior segments. The previously described association between ST elevation and increased mortality may be mediated by myocardial scar.
BACKGROUND: The mechanism of ST elevation on baseline electrocardiograms (ECG) unknown but it may be associated with abnormal myocardial substrate. This paper evaluates whether clinically unrecognized myocardial scar on cardiac magnetic resonance imaging (CMR) is associated with ST elevation at baseline. METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) study is a population-based cohort in the United States. Participants were aged 45 through 84 years and free of clinical cardiovascular disease at enrollment in 2000-2002. Our cohort included 1365 participants who underwent both ECG and contrast enhanced CMR in the 5th examination (2010-2012). Multivariable logistic regression examined the association of ST elevation and CMR defined regional myocardial scar after adjusting for cardiovascular risk factors. RESULTS: Of 1365 participants (58 ±9 years, 52% men), 105 (8%) had scar on CMR. Of these, the scar in 40 participants followed an ischemic pattern and in the other 65 participants followed a non-ischemic pattern. ST elevation at the 5th examination was present in 435 participants: 40 (0.9%) had ST elevations in inferior and 427 (98%) in lateral leads. 2/40 (5%) and 22/427 (5%) participants with inferior and lateral ST elevations, respectively, had evidence of scar. 15 (1.0%) had myocardial scar noted in the basal anterior region. In the fully adjusted models, ST elevation was associated with scar in basal anterior region (OR 18.2, p = 0.031). CONCLUSIONS: In a community population, ST elevation at baseline in the inferior or lateral leads was associated with myocardial scar in the basal inferior and anterior segments. The previously described association between ST elevation and increased mortality may be mediated by myocardial scar.
Authors: Saman Nazarian; David A Bluemke; Albert C Lardo; Menekhem M Zviman; Stanley P Watkins; Timm L Dickfeld; Glenn R Meininger; Ariel Roguin; Hugh Calkins; Gordon F Tomaselli; Robert G Weiss; Ronald D Berger; João A C Lima; Henry R Halperin Journal: Circulation Date: 2005-11-01 Impact factor: 29.690
Authors: Raphael Rosso; Evgeni Kogan; Bernard Belhassen; Uri Rozovski; Melvin M Scheinman; David Zeltser; Amir Halkin; Arie Steinvil; Karin Heller; Michael Glikson; Amos Katz; Sami Viskin Journal: J Am Coll Cardiol Date: 2008-10-07 Impact factor: 24.094
Authors: Michel Haïssaguerre; Fabrice Extramiana; Mélèze Hocini; Bruno Cauchemez; Pierre Jaïs; Jose Angel Cabrera; Jerónimo Farré; Gerónimo Farre; Antoine Leenhardt; Prashanthan Sanders; Christophe Scavée; Li-Fern Hsu; Rukshen Weerasooriya; Dipen C Shah; Robert Frank; Philippe Maury; Marc Delay; Stéphane Garrigue; Jacques Clémenty Journal: Circulation Date: 2003-08-18 Impact factor: 29.690
Authors: Michel Haïssaguerre; Nicolas Derval; Frederic Sacher; Laurence Jesel; Isabel Deisenhofer; Luc de Roy; Jean-Luc Pasquié; Akihiko Nogami; Dominique Babuty; Sinikka Yli-Mayry; Christian De Chillou; Patrice Scanu; Philippe Mabo; Seiichiro Matsuo; Vincent Probst; Solena Le Scouarnec; Pascal Defaye; Juerg Schlaepfer; Thomas Rostock; Dominique Lacroix; Dominique Lamaison; Thomas Lavergne; Yoshifusa Aizawa; Anders Englund; Frederic Anselme; Mark O'Neill; Meleze Hocini; Kang Teng Lim; Sebastien Knecht; George D Veenhuyzen; Pierre Bordachar; Michel Chauvin; Pierre Jais; Gaelle Coureau; Genevieve Chene; George J Klein; Jacques Clémenty Journal: N Engl J Med Date: 2008-05-08 Impact factor: 91.245
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Raymond Y Kwong; Hamid Sattar; Henry Wu; Gabriel Vorobiof; Vijay Gandla; Kevin Steel; Samuel Siu; Kenneth A Brown Journal: Circulation Date: 2008-08-25 Impact factor: 29.690
Authors: Erik B Schelbert; Jie J Cao; Sigurdur Sigurdsson; Thor Aspelund; Peter Kellman; Anthony H Aletras; Christopher K Dyke; Gudmundur Thorgeirsson; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Tamara B Harris; Andrew E Arai Journal: JAMA Date: 2012-09-05 Impact factor: 56.272